ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,022.21
      -0.58%
      US Tech 100
      17,055.60
      -1.09%
      Dow Jones
      37,753.31
      -0.12%
      Brent Oil
      86.985
      -2.88%
      Bitcoin
      61,439.42
      -3.77%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Merck and Co Inc (MRK)

      7. Merck and Co Inc (MRK) News

      MRK Merck and Co Inc

      125.40
      0.34 (0.27%)
      After Hours
      Last Updated: 17:19:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Merck and Co Inc MRK NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.34 0.27% 125.40 17:19:00
      Open Price Low Price High Price Close Price Prev Close
      126.23 124.71 126.23 125.37 125.06
      more quote information »

      Recent News

      Date Time Source Heading
      4/17/20248:00IHNWFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
      4/10/202407:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
      4/04/202406:45BWMerck Initiates Phase 3 Clinical Trial of MK-1084, an..
      4/03/202408:00BWREJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan..
      4/01/202406:45BWMerck to Hold First-Quarter 2024 Sales and Earnings..
      3/28/202406:45BWEuropean Commission Approves Merck’s KEYTRUDA®..
      3/27/202406:54IHMARKETNEWSGameStop Shares Tumble 20% in Pre-Market Trading Amid..
      3/26/202418:21BWFDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a..
      3/21/202406:45BWMerck Provides Update on Phase 3 KEYLYNK-006 Trial..
      3/19/202409:00BWMerck Announces Positive Data on V116, an Investigational,..
      3/15/202416:23PRNUSFarmSee Ltd Announces the Completion of a Minority..
      3/15/202406:45BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy..
      3/13/202403:00BWMerck Announces Plans to Conduct Clinical Trials of a Novel..
      3/11/202408:15BWMerck Completes Acquisition of Harpoon Therapeutics, Inc.
      3/06/202410:25BWGilead and Merck Announce Phase 2 Data Showing an..
      3/05/202409:03IHMARKETNEWSFutures Pointing To Continued Weakness On Wall Street
      3/05/202406:45BWMerck to Participate in the Barclays 26th Annual Global..
      3/04/202406:45BWMerck to Participate in the Leerink Partners Global..
      2/27/202406:45BWMerck to Participate in the TD Cowen 44th Annual Health Care..
      2/23/202406:20BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
      2/20/202416:14EDGAR2Form 8-K - Current report
      2/20/202406:45BWFDA Grants Priority Review to Merck's Application for..
      2/15/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202416:40EDGAR2Form 144 - Report of proposed sale of securities
      2/14/202416:30EDGAR2Form 144 - Report of proposed sale of securities
      2/14/202416:24EDGAR2Form 144 - Report of proposed sale of securities
      2/13/202416:50EDGAR2Form 144 - Report of proposed sale of securities
      2/13/202416:48EDGAR2Form 144 - Report of proposed sale of securities
      2/12/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/12/202407:05PRNCASanté Canada approuve KEYTRUDA®, en association avec le..
      2/09/202416:06EDGAR2Form 144 - Report of proposed sale of securities
      2/08/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/08/202407:00PRNCAMERCK CANADA ANNOUNCES COLLABORATION WITH VECTOR INSTITUTE..
      2/07/202416:09EDGAR2Form 144 - Report of proposed sale of securities
      2/05/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202406:33BWMerck Animal Health to Acquire Elanco’s Aqua Business
      2/02/202416:35EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202416:09EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202416:08EDGAR2Form 144 - Report of proposed sale of securities
      2/02/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/01/202406:39EDGAR2Form 8-K - Current report
      2/01/202406:30BWMerck Announces Fourth-Quarter and Full-Year 2023 Financial..
      1/27/202410:00BWMerck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Death..
      1/26/202411:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/26/202410:00BWMerck’s KEYTRUDA® (pembrolizumab) Significantly Improved..
      1/25/202408:07DJNLava Therapeutics Shares Rise as Drug Set for Test With..
      1/24/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NYSE
      MRK
      Merck
      Delayed Upgrade Clock